AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
Log in

NYSE:HCPHCP Stock Price, Forecast & News

$24.64
-0.95 (-3.71 %)
(As of 06/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$24.35
Now: $24.64
$25.20
50-Day Range
$21.94
MA: $25.05
$28.35
52-Week Range
$26.58
Now: $24.64
$37.93
Volume21.77 million shs
Average Volume2.80 million shs
Market Capitalization$12.10 billion
P/E Ratio13.54
Dividend Yield4.03%
Beta0.22
HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Read More
HCP logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 1.9Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.98 out of 5 stars


Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustrySpecialized REITs
SectorFinance
CUSIP40414L10
Phone949-407-0700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.85 billion
Cash Flow$2.31 per share
Book Value$13.70 per share

Profitability

Net Income$1.06 billion

Miscellaneous

Employees201
Market Cap$12.10 billion
Next Earnings Date7/29/2020 (Estimated)
OptionableOptionable

Receive HCP News and Ratings via Email

Sign-up to receive the latest news and ratings for HCP and its competitors with MarketBeat's FREE daily newsletter.

HCP (NYSE:HCP) Frequently Asked Questions

How has HCP's stock been impacted by COVID-19 (Coronavirus)?

HCP's stock was trading at $32.10 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, HCP shares have decreased by 23.2% and is now trading at $24.64. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of HCP?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCP in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for HCP.

When is HCP's next earnings date?

HCP is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for HCP.

How were HCP's earnings last quarter?

HCP, Inc. (NYSE:HCP) posted its earnings results on Wednesday, October, 30th. The real estate investment trust reported ($0.09) EPS for the quarter, missing the consensus estimate of $0.43 by $0.52. The real estate investment trust earned $538 million during the quarter, compared to analysts' expectations of $503.65 million. HCP had a return on equity of 12.78% and a net margin of 43.66%. The company's revenue for the quarter was up 18.0% on a year-over-year basis. During the same period last year, the firm earned $0.44 EPS. View HCP's earnings history.

How often does HCP pay dividends? What is the dividend yield for HCP?

HCP declared a quarterly dividend on Wednesday, October 23rd. Shareholders of record on Monday, November 4th will be given a dividend of $0.37 per share on Tuesday, November 19th. This represents a $1.48 annualized dividend and a yield of 6.01%. The ex-dividend date is Friday, November 1st. View HCP's dividend history.

What price target have analysts set for HCP?

8 equities research analysts have issued 1 year price targets for HCP's shares. Their forecasts range from $35.00 to $39.00. On average, they expect HCP's share price to reach $37.00 in the next twelve months. This suggests a possible upside of 50.2% from the stock's current price. View analysts' price targets for HCP.

Has HCP been receiving favorable news coverage?

News stories about HCP stock have trended very negative this week, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. HCP earned a coverage optimism score of -3.0 on InfoTrie's scale. They also gave headlines about the real estate investment trust a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutHCP.

Who are some of HCP's key competitors?

What other stocks do shareholders of HCP own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HCP investors own include AT&T (T), Welltower (WELL), Omega Healthcare Investors (OHI), AbbVie (ABBV), Intel (INTC), Cisco Systems (CSCO), Realty Income (O), Verizon Communications (VZ), Walt Disney (DIS) and Johnson & Johnson (JNJ).

Who are HCP's key executives?

HCP's management team includes the following people:
  • Mr. Thomas M. Herzog, Pres, CEO & Director (Age 56)
  • Mr. Peter A. Scott, Exec. VP & CFO (Age 39)
  • Mr. Thomas M. Klaritch, Exec. VP, COO & Chief Devel. Officer (Age 61)
  • Mr. Scott M. Brinker, Exec. VP & Chief Investment Officer (Age 42)
  • Mr. Troy E. McHenry, Exec. VP, Gen. Counsel & Corp. Sec. (Age 46)

What is HCP's stock symbol?

HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP."

How do I buy shares of HCP?

Shares of HCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is HCP's stock price today?

One share of HCP stock can currently be purchased for approximately $24.64.

How big of a company is HCP?

HCP has a market capitalization of $12.10 billion and generates $1.85 billion in revenue each year. The real estate investment trust earns $1.06 billion in net income (profit) each year or $1.82 on an earnings per share basis. HCP employs 201 workers across the globe.

What is HCP's official website?

The official website for HCP is www.hcpi.com.

How can I contact HCP?

HCP's mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust can be reached via phone at 949-407-0700 or via email at [email protected]

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.